Skip to main content

Table 2 Quality evaluation of the included cohort studies via the NOS

From: Efficacy and safety of tenofovir disoproxil fumarate versus entecavir in the treatment of acute-on-chronic liver failure with hepatitis B: a systematic review and meta-analysis

Studies

Representativeness of the exposed cohort

Selection of the nonexposed cohort

Ascertainment of exposure

Outcome not present at baseline

Control for age and sex

Control for other confounding factors

Assessment of outcome

Enough long follow-up duration

Adequacy of follow-up of cohort

Total

Hossain et al. [17]

 

  

6

Zhang et al. [13]

 

 

7

Zhang et al. [16]

 

8

Li et al. [14]

 

8

Wan et al. [15]

 

8

  1. TDF Tenofovir, ETV Entecavir, NR Not reported